FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
Regulatory Approvals
As FDA approves new marketing for nicotine pouches, some doctors sound alarms
As FDA approves new marketing for nicotine pouches, some doctors sound alarms CBS News
FDA Approves Orexin Agonist Oveporexton for Narcolepsy Type 1
FDA Approves Orexin Agonist Oveporexton for Narcolepsy Type 1 NeurologyLive
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms Psychiatric Times
Galaxy Therapeutics’ SEAL embolization system gets CE mark
Galaxy Therapeutics’ SEAL embolization system gets CE mark MassDevice